| Name | Title | Contact Details |
|---|
FORA is a Newbury Park, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Tech-Med Services is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Infusion Express offers the IV therapy you need in a place and time that works for you. We work around your schedule by offering weekday, evening and Saturday appointments. All of our patients are treated in private suites fully equipped with WiFi, flat screen TVs, and comfortable recliners. Feel free to bring a friend or family member with you. At Infusion Express taking care of you is our number one priority. We are committed to making you better in a better way!
Cook Biotech / Biodesign is a West Lafayette, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.